Location History:
- Zeist, NL (2015 - 2021)
- Utrecht, NL (2020 - 2023)
Company Filing History:
6 out of 21 
1 out of 48 
Years Active: 2015-2023
Title: The Innovations of Albert Van Dijk
Introduction: Albert Van Dijk, an accomplished inventor based in Zeist, Netherlands, is renowned for his contributions to the field of antimicrobial peptides. With a total of six patents to his name, his work primarily focuses on developing innovative solutions to combat infections and enhance vaccine efficacy.
Latest Patents: Among his recent patents, the development of CATH2 derivatives stands out. This invention includes new derivatives of CATH2 or CMAP27, which are types of cathelicidins. These derivatives feature N-terminally truncated peptides, cyclic peptides, D-amino acid variants of CATH2, and their truncated counterparts, as well as inverso and retroinverso CATH2 derivatives. These innovative peptides hold significant potential for use as anti-infectives, in vaccines, and particularly for in ovo applications. Moreover, novel immunoactivating functions have been described for these derivatives, providing advantages in prophylactic treatments. Another significant patent involves antimicrobial peptides based on CMAP27, focusing on derivatives with good antimicrobial activity yet low hemolytic activity compared to the wild-type CMAP27 peptide. These derivatives are applicable in antibiotic therapy and bactericidal compositions and can also function as adjuvants.
Career Highlights: Albert Van Dijk has made his mark in the scientific community through his innovative research. His prominent roles in companies such as Universiteit Utrecht Holding B.V. and UMC Utrecht Holding B.V. reflect his commitment to advancing medical science and creating impactful inventions.
Collaborations: Throughout his career, Van Dijk has collaborated with esteemed colleagues, including Hendrik Peter Haagsman and Edwin Johannes Adrianus Veldhuizen. These partnerships have fostered a collaborative environment that drives innovation in developing new antimicrobial solutions.
Conclusion: Albert Van Dijk's inventive spirit and dedication to research have significantly advanced the field of antimicrobial peptides. His six patents demonstrate his ability to innovate and address pressing challenges in infection management and vaccine development. Through collaboration and a strong foundation in research institutions, he continues to pave the way for future breakthroughs in healthcare.